ALMR logo

ALAMAR BIOSCIENCES INC

ALMRNASDAQ
๐Ÿ† #1883 by market capEarnings Feb 2US Equity
โ€”โ€”
Quote unavailable
๐Ÿ””
Track ALMR
Get earnings, price moves & breaking news on Telegram
Track
24hโ€”
7dโ€”
14dโ€”
30dโ€”
ytdโ€”
1yโ€”
๐ŸฆMarket Cap
$1.84B
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
0.0%
Slowing
๐Ÿ“ŠGross Margin
59.3%
Healthy
๐Ÿ’ตFCF Margin
-60.1%
Thin
โš–๏ธP/S Ratio
16.1x
Expensive
Otter Score
โ€”
Insufficient data
No chart data available for ALMR.

Trading Snapshot

Day Range
โ€”
52-Week Range
$18.85 โ€“ $39.61
Volume (shares)
โ€”
Avg Volume (shares)
โ€”
Shares Outstanding
69.5M
Next Earnings
2027-02-02

Fundamentals Snapshot

Annual Revenue
$74M
Last Q Revenue
$34M
P/E Ratio
-31.9
P/S Ratio
16.1x
EPS (TTM)
$-0.80
Dividend Yield
0.00%
ALMR logo

ALAMAR BIOSCIENCES INC

ALMR
Financial Trends

Financial history unavailable.

StockOtter ยท stockotter.space

About ALAMAR BIOSCIENCES INC

Alamar Biosciences operates as a commercial-stage proteomics firm, specializing in the highly sensitive, simultaneous identification of various proteins for both scientific research and prospective medical applications. Their integrated platform brings together proprietary instruments, specialized consumables, and unique software, forming a comprehensive, end-to-end solution. This system is designed for accurately quantifying multiple proteins, particularly those present in low concentrations, across a wide array of research and potential clinical uses.

๐Ÿฆฆ

Otter Score Breakdown

How it's scoredFive components, each rated 1โ€“5โ˜… and equally weighted (20%), averaged to a 0โ€“100 score:๐Ÿ’Ž Quality โ€” gross margin๐Ÿš€ Growth โ€” revenue YoYโš–๏ธ Valuation โ€” P/S ratioโšก Momentum โ€” 30-day price change๐Ÿ’ง Dilution โ€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
โšกMomentumโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Insufficient data
โ€”/100
Analyst data unavailable.

Latest News & Updates

News unavailable.